By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Fresh data on Biotechnology are presented in a new report. According to news originating from Jiangsu, People's Republic of China, by NewsRx correspondents, research stated, "Transducer of erbB2.1 (TOB1) is a member of the B-cell translocation gene (BTG)/transducer of erbB2 (TOB) anti?proliferative protein family. Previous studies have demonstrated that overexpression of TOB1 significantly enhances the radiosensitivity of breast and cervical cancer cells."
Our news journalists obtained a quote from the research from Jiangsu University, "However, the potential mechanisms of TOB1 are still debated. In the present study, we evaluated the effects of infrared (IR) radiation on TOB1 expression in the human lung cancer cell lines NCI-H1975 and A549 via western blot analysis. NCI-H1975 cells were transfected with TOB1 recombinant plasmid, and A549 cells were treated with TOB1-small interfering RNA (siRNA) to establish gain-of-function and loss-of?function cell models. The effects of radiation and TOB1 overexpression and silencing on clonogenic survival, cell cycle distribution and DNA repair were assessed. Western blot analysis was performed to determine the related mechanisms. The expression levels of TOB1 were significantly induced by IR radiation. Overexpression of TOB1 abrogated radiation-induced G2/M arrest, reduced clonogenic cell survival and enhanced ?-H2AX foci in NCI-H1975 cells exposed to irradiation. TOB1-siRNA demonstrated opposite effects in A549 cells. TOB1 regulated the activation of mitogen-activated protein kinase (MAPK) and modulated the phosphorylation of p53 via activation of the MAPK/extracellular signal-regulated kinase (ERK) pathway. The findings suggest that TOB1 may be a novel molecular target of irradiation."
According to the news editors, the research concluded: "TOB1 modulated the radiosensitivity of lung cancer cells via the MAPK/ERK signaling pathway."
For more information on this research see: Enhanced radiosensitivity of NSCLC cells by transducer of erbB2.1 (TOB1) through modulation of the MAPK/ERK pathway. Oncology Reports, 2013;29(6):2385-91 (see also technology.html">Biotechnology).
The news correspondents report that additional information may be obtained from K.K. Sun, Dept. of Gastrointestinal Surgery Division of Thoracic Surgery, Kunshan First People's Hospital Affiliated to Jiangsu University, Kunshan, Jiangsu 215300, People's Taiwan. Additional authors for this research include N. Zhong, Y. Yang, L. Zhao and Y. Jiao.
Keywords for this news article include: Asia, Biotechnology, Jiangsu, Oncology, Cancer Gene Therapy, People's Republic of China.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC